Mechanisms of Lifespan Regulation by Calorie Restriction and Intermittent Fasting in Model Organisms

Nutrients. 2020 Apr 24;12(4):1194. doi: 10.3390/nu12041194.

Abstract

Genetic and pharmacological interventions have successfully extended healthspan and lifespan in animals, but their genetic interventions are not appropriate options for human applications and pharmacological intervention needs more solid clinical evidence. Consequently, dietary manipulations are the only practical and probable strategies to promote health and longevity in humans. Caloric restriction (CR), reduction of calorie intake to a level that does not compromise overall health, has been considered as being one of the most promising dietary interventions to extend lifespan in humans. Although it is straightforward, continuous reduction of calorie or food intake is not easy to practice in real lives of humans. Recently, fasting-related interventions such as intermittent fasting (IF) and time-restricted feeding (TRF) have emerged as alternatives of CR. Here, we review the history of CR and fasting-related strategies in animal models, discuss the molecular mechanisms underlying these interventions, and propose future directions that can fill the missing gaps in the current understanding of these dietary interventions. CR and fasting appear to extend lifespan by both partially overlapping common mechanisms such as the target of rapamycin (TOR) pathway and circadian clock, and distinct independent mechanisms that remain to be discovered. We propose that a systems approach combining global transcriptomic, metabolomic, and proteomic analyses followed by genetic perturbation studies targeting multiple candidate pathways will allow us to better understand how CR and fasting interact with each other to promote longevity.

Keywords: aging; calorie restriction; fasting; lifespan; longevity.

Publication types

  • Review

MeSH terms

  • Aging
  • Animals
  • Biomarkers
  • Caloric Restriction*
  • Diet
  • Energy Intake
  • Fasting*
  • Humans
  • Longevity*
  • Models, Animal
  • Species Specificity

Substances

  • Biomarkers

Grants and funding